The pet biotics market is estimated at USD 878.1 million in 2025 and is projected to reach USD 1,232.5 million by 2030, at a CAGR of 7.0% from 2025 to 2030. The global pet biotics market is expanding rapidly as pet owners increasingly prioritize digestive health, immunity, and overall wellness for their companion animals. The growing trend of pet humanization, rising awareness of the gut–health connection, and the shift toward functional, science-backed nutrition are major drivers boosting the use of probiotics, prebiotics, and postbiotics in pet food and supplements. Advances in formulation technologies, clean-label trends, and the demand for customized health solutions are creating strong opportunities for innovative biotic ingredients that enhance stability, efficacy, and targeted benefits, such as improved skin health, stress reduction, and enhanced nutrient absorption.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89829007
The probiotics product type segment is expected to hold the highest market share during the forecast period.
Probiotics are expected to hold the highest market share in the pet biotics market during the forecast period, driven by their well-established role in supporting digestive balance, immune function, and overall gut health in companion animals. According to the International Probiotics Association (IPA), among a sample of 754 dog and cat owners, 32% reported purchasing a pet supplement within the past 12 months. This statistic serves as a measurable indicator of the growing consumer adoption of pet health supplements, marking a strong foundation for the biotic products segment, which includes probiotics, prebiotics, and postbiotics. Probiotics are the most frequently recognized ingredient category associated with health-promoting properties, cited by 32% of respondents. Probiotic strains, such as Lactobacillus and Bifidobacterium, are widely recognized and trusted by veterinarians and pet owners, which has contributed to their strong adoption in pet foods, supplements, and functional treats. The growing awareness of the importance of the pet gut microbiome, combined with increasing incidences of digestive disorders, allergies, and stress-related issues in pets, is further accelerating the inclusion of probiotics in daily nutrition products. Additionally, the availability of species-specific probiotic formulations and advancements in microencapsulation and stabilization technologies have improved product efficacy and compatibility with commercial pet food processing methods. These factors position probiotics as the leading ingredient category within the pet biotics market, supporting their dominance throughout the forecast period.
What is Pet Biotics?
Pet biotics refer to a broad category of products containing prebiotics, probiotics, and postbiotics designed to maintain a healthy balance of good bacteria in an animal’s digestive system. These beneficial microorganisms play a crucial role in nutrient absorption, immune function, metabolism, and even behaviour.
Types of Biotics Used in Pet Nutrition
- Probiotics: Live beneficial bacteria supporting digestive and immune health
- Prebiotics: Fibers that fuel good bacteria growth
- Postbiotics: Metabolites produced during fermentation, offering targeted health benefits
Together, these ingredients help maintain a stable microbiome, essential for pets’ long-term well-being.
Why Pet Biotics Are Growing in Popularity?
- Rise of Pet Humanization: Pets are no longer just animals—they’re part of the family. This shift has encouraged pet owners to seek high-quality, functional nutrition similar to human-grade products. Biotics help enhance digestion, nutrient absorption, and immune response, making them a preferred choice for health-conscious owners.
- Increasing Digestive Health Issues: Digestive disorders such as diarrhea, constipation, and food sensitivities are becoming more common in pets. Probiotics and prebiotics offer natural, safe solutions that restore gut flora balance and support overall digestive comfort.
- Expanding Product Innovations: From supplements and treats to fortified kibble and wet food, pet biotics now come in diverse formats. Companies are investing in species-specific strains, advanced delivery technologies, and long-lasting formulations that ensure better efficacy.
- Growing Veterinary Recommendations: Veterinarians increasingly recommend biotics to manage gastrointestinal conditions, improve coat health, reduce allergies, and boost immunity. This professional support significantly influences consumer purchasing decisions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89829007
The supplements application segment is expected to hold a significant market share in the pet biotics market during the forecast period.
The supplements application segment is driven by increasing demand for targeted health solutions addressing digestive wellness, immunity, skin and coat health, and stress management in companion animals. Supplements offer flexible dosage formats, including powders, capsules, tablets, and soft chews, allowing pet owners to deliver concentrated and clinically supported biotic benefits tailored to specific pet needs and life stages. The rising trend of preventive care, growing veterinarian recommendations for microbiome support, and rapid expansion of e-commerce and specialty pet retail channels are further accelerating adoption. As consumers increasingly seek premium, science-backed products for daily wellness routines, supplements continue to gain traction over traditional food formats, positioning the segment to command a leading share in the pet biotics market.
The Asia Pacific region is estimated to be the fastest-growing region in the global pet biotics market.
Asia Pacific is emerging as the fastest-growing region in the pet biotics market, driven by rapid urbanization, increasing pet ownership, and the growing trend of pet humanization across countries such as China, India, Japan, and South Korea. As more households view pets as family members, pet owners are becoming increasingly conscious of preventive healthcare, digestive wellness, and immunity-boosting nutrition, resulting in a rising demand for functional ingredients such as probiotics, prebiotics, and postbiotics. The region is also witnessing strong expansion in premium pet food, veterinary clinics, and e-commerce platforms, making innovative functional pet nutrition more accessible. Additionally, increasing awareness of microbiome health and the influence of the gut–brain–skin axis in pets is encouraging manufacturers to incorporate science-backed biotics into dry kibble, supplements, treats, and therapeutic diets. Local and global companies are accelerating product launches and partnerships to meet this demand, positioning Asia Pacific as the fastest-growing region in the global pet biotics market.
The report profiles key players such as ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc. (US), BENEO GmbH (Germany), Ingredion (US), Lallemand Inc. (Canada), Sacco System (Italy), Phileo by Lesaffre (France), Sanzyme Biologics (India), Orffa (Netherlands), BIO-CAT (US), and others.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=89829007
Market Outlook & Future Trends
- The pet biotics market is poised for strong, sustained growth over the next decade because of the increasing convergence of pet wellness and microbiome science.
- As research deepens, postbiotics may become more prominent: they are generally more stable (since they are not live organisms) but still retain functional benefits.
- Regulatory clarity will improve, helping both manufacturers and consumers. As safety and efficacy data grow, more targeted health claims could be approved.
- There’s likely to be greater integration of biotics in mainstream pet food (not just as supplements) — premium kibble or wet food formulated with live bacteria or prebiotics.
- Global adoption will be uneven but strong growth is expected particularly in emerging markets, as pet ownership rises in Asia and Latin America.
Recent Developments in the Pet Biotics Industry:
- June 2025, ADM opened a 1,600 m², state-of-the-art R&D center at Lausanne’s biopôle campus in Switzerland to conduct pre-clinical microbiome research for pets, livestock, and aquaculture—leveraging biotics and fermentation-derived ingredients to improve gut health, immunity, digestion, and longevity. This launch reflects the booming USD 5.2 billion global animal feed biotics market (as of 2024) and growing consumer and producer demand for science-backed nutritional solutions.
- August 2024, Kerry announced a two-year strategic partnership with APC Microbiome Ireland at University College Cork to collaboratively research and develop novel biotic and postbiotic ingredients targeting the gut–brain axis, with the aim of improving cognitive health and mood, and a rapid market rollout following project completion.
- July 2024, Cargill signed an exclusive distribution agreement with Brenntag Specialties Nutrition for its postbiotic ingredient EpiCor, made from fermented baker’s yeast (Saccharomyces cerevisiae). This deal encompasses a broad range of European regions, including the UK, Ireland, France, Germany, the Nordics, the Baltics, and others. EpiCor is known for supporting immune and gut health, and this partnership aims to meet growing demand for functional health ingredients across Europe.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pet-biotics-market-89829007.html